Kristopher Jonas: Why Donors Show Up and Why It All Matters
Kristopher Jonas, Chief Executive Officer/President at Proesis Biologics, shared a post on LinkedIn:
”This recent piece from Peter Jaworski that sparked a different reflection for me.
In plasma, we spend a lot of time talking about why people donate.
But the truth is, people show up for different reasons. And, they’re all valid.
- Some are motivated by helping patients
- Some are motivated by the compensation
- Some are in between
Here’s the part that matters:
Our responsibility isn’t to judge the reason. It’s to respect the decision.
Because regardless of why someone walks through the door…they are contributing to a system that patients depend on.
And that deserves to be met with:
- Respect
- Dignity
- Appreciation
Every single time.
If we want to build a sustainable plasma supply, this principle has to be foundational:
- Fierce donor advocacy means showing up for the donor, without conditions.
- Not when it’s convenient.
- Not when it fits a narrative.
- Every time.
That’s how trust is built.
And in this industry, trust is everything.”

Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia